Drug companies have cut nearly 69,000 pharmaceutical jobs since the start of 2021. A single biotech job posting now attracts ...

Exciting news for students at Patliputra University! The schedule for the Part-I vocational degree examinations is officially ...

The Intersection of Science and Business Scope of MBA after BSc: Is it feasible for students with a science background to ...

Bioversity, which spun out of MassBio in 2023, opened its first training center in Boston’s Dorchester neighborhood in ...

A Woburn biotechnology company is now facing a significantly larger wave of layoffs than initially disclosed — with state filings suggesting between 161 and 224 Massachusetts employees are on the ...

Biopharma companies appear to be more willing to go public after a long drought. Just this week, GLP-1 developer Kailera Therapeutics and proteomics company Alamar Biosciences launched IPO roadshows ...

The Spanish government has announced a goal to raise a $200 million venture capital fund as part of a biotech initiative focused on Boston. The partnership aims to “build bridges” with the Boston ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The U.S. labor market showed signs of improvement in March, with employers adding 178,000 ...

Half a year after being spurned by the FDA and following deep layoffs, IO Biotech has decided to close its doors for good. The Danish biotech has ceased operations and said goodbye to its employees, C ...

A new Philly nonprofit is trying to close a gap in the city’s life sciences ecosystem: meaningful connections between students and industry professionals. After their own unconventional experiences ...

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s most advanced immuno-oncology asset, the prostate cancer candidate VIR-5500, through a collaboration that could ...